The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
The effect of blocking immune checkpoints LAG-3 and PD-1 on human invariant Natural Killer T cell function ; volume:13 ; number:1 ; day:21 ; month:6 ; year:2023 ; pages:1-12 ; date:12.2023
Scientific reports ; 13, Heft 1 (21.6.2023), 1-12, 12.2023
- Urheber
-
Balasko, Allison L.
Kowatsch, Monika M.
Graydon, Colin
Lajoie, Julie
Fowke, Keith R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-36468-8
- URN
-
urn:nbn:de:101:1-2023092210155292415528
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
09.07.2025, 15:18 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Balasko, Allison L.
- Kowatsch, Monika M.
- Graydon, Colin
- Lajoie, Julie
- Fowke, Keith R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
PD‐1 blocking antibodies moonlighting as killers
Novel immune checkpoints beyond PD-1 in advanced melanoma
Defining innate immune checkpoints controlling Natural Killer cell recognition of melanoma cells
Invariant natural killer T cells in lung diseases
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Grundlagen: Signalwege und Checkpoints
Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
Comparative Analysis of Inhibitory and Activating Immune Checkpoints PD-1, PD-L1, CD28, and CD86 in Non-Melanoma Skin Cancer
PD‐1 blocking antibodies moonlighting as killers
Novel immune checkpoints beyond PD-1 in advanced melanoma
Defining innate immune checkpoints controlling Natural Killer cell recognition of melanoma cells
Invariant natural killer T cells in lung diseases
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Grundlagen: Signalwege und Checkpoints
Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
Comparative Analysis of Inhibitory and Activating Immune Checkpoints PD-1, PD-L1, CD28, and CD86 in Non-Melanoma Skin Cancer
PD‐1 blocking antibodies moonlighting as killers
Novel immune checkpoints beyond PD-1 in advanced melanoma
Defining innate immune checkpoints controlling Natural Killer cell recognition of melanoma cells
Invariant natural killer T cells in lung diseases
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review
MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways
Grundlagen: Signalwege und Checkpoints
Blocking the PD-1/PD-L1 pathway in glioma: a potential new treatment strategy
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases